Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Nigrostriatal dopamine depletion disrupts striatal medium spiny neuron morphology in Parkinson's disease and modulates striatal synaptic plasticity in animal models of parkinsonism. We demonstrate that long‐term nigrostriatal dopamine depletion in the rat induces evolving changes in the phosphorylation of striatal proteins critical for synaptic plasticity. Dopamine depletion increased the phosphorylation of the alpha isoform of calcium–calmodulin‐dependent protein kinase II (CaMKIIα) at Thr 286, a site associated with enhanced autonomous kinase activity, but did not alter total levels of CaMKIIα or other synaptic proteins. Dopamine depletion decreased CaMKIIα levels in postsynaptic density‐enriched fractions without significant changes in other proteins. The activity of protein phosphatase 1 (PP1), a postsynaptic phosphatase that dephosphorylates CaMKII, is regulated by DARPP‐32 (dopamine‐ and cAMP‐regulated phosphoprotein of 32 kDa). Dopamine depletion had no effect on DARPP‐32 phosphorylation at Thr 34, but increased DARPP‐32 phosphorylation at Thr 75. Levodopa administration reversed the increased phosphorylation of both CaMKIIα and DARPP‐32. Normal ageing increased the levels of PP1(γ1 isoform) but decreased levels of the PP1γ1‐targeting proteins spinophilin and neurabin. Elevated phosphorylations of CaMKIIα and DARPP‐32 were maintained for up to 20 months after dopamine depletion. However, phosphorylation of the CaMKII–PP1 substrate, Ser 831 in the glutamate receptor GluR1 subunit, was increased only after sustained (9–20 months) dopamine depletion. Interaction of ageing‐related changes in PP1 with the dopamine depletion‐induced changes in CaMKIIα may account for enhanced GluR1 phosphorylation only after long‐term dopamine depletion. These evolving changes may impact striatal synaptic plasticity, Parkinson's disease progression and the changing efficacy and side‐effects associated with dopamine replacement therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588 · cited 1×
“…(Snyder et al., 2000; Chao et al., 2002), and CaMKII regulates the unitary conductance and trafficking ª 2005 Federation of European Neuroscience Societies, European Journal of Neuroscience, 22, 247–256 of AMPA-type glutamate receptors (Malinow & Malenka, 2002; Malinow, 2003; Allen, 2004).”
BackgroundThe molecular basis of CaMKII function in synaptic and behavioural memory
Lisman, J., Schulman, H., & Cline, H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn753 · Cited by 1,860 · cited 4×
“Moreover, normal synaptic plasticity requires phosphorylation of CaMKII at Thr(286) (Lisman et al., 2002; Colbran & Brown, 2004) and of AMPA receptor GluR1 subunits (Lee et al.”
BackgroundInfluentialRegulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity
Lee, H.-K., Barbarosie, M., Kameyama, K., Bear, M. F., & Huganir, R. L. (2000) · Nature · doi:10.1038/35016089 · Cited by 1,116 · cited 6×
“GluR1 phosphorylation depends not only on CaMKII activity but also on the activity of opposing phosphatases, such as PP1 ⁄ PP2A and PP2B (Lee et al., 2000; Snyder et al., 2000; Vinade & Dosemeci, 2000).”
BackgroundInfluentialLoss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821 · cited 2×
“Surprisingly, but consistent with prior reports (Picconi et al., 2003; Chergui et al., 2004), there were no significant changes in Thr(34)”
ResultLee, H.-K., Takamiya, K., Han, J.-S., Man, H., Kim, C.-H., Rumbaugh, G., Yu, S., Ding, L., He, C., Petralia, R. S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00122-3 · Cited by 802
Shen, K., & Meyer, T. (1999) · Science · doi:10.1126/science.284.5411.162 · Cited by 673 · cited 1×
“…of CaMKIIa confers autonomous (Ca2+– calmodulin-independent) kinase activity (Hudmon & Schulman, 2002; Colbran & Brown, 2004) and stabilizes CaMKII binding to PSD proteins and synapses in hippocampal neurons (Strack et al., 1997; Yamauchi & Yoshimura, 1998; Shen & Meyer, 1999; Colbran, 2004a).”
BackgroundStructure–function of the multifunctional Ca2+/calmodulin-dependent protein kinase II
HUDMON, A., & SCHULMAN, H. (2002) · Biochemical Journal · doi:10.1042/bj20020228 · Cited by 615
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease
Zaja-Milatovic, S., Milatovic, D., Schantz, A. M., Zhang, J., Montine, K. S., Samii, A., Deutch, A. Y., & Montine, T. J. (2005) · Neurology · doi:10.1212/01.wnl.0000150591.33787.a4 · Cited by 300 · cited 4×
“…in MSN dendrites have been reported in Parkinson’s disease (McNeill et al., 1988; Ingham et al., 1998; Arbuthnott et al., 2000; Meshul et al., 2000; Zaja-Milatovic et al., 2005) and in a rat model of parkinsonism induced by 6-hydroxydopamine (6-OHDA) lesion of the substantia nigra (Ingham et al.,…”
BackgroundInfluentialSelf-citationInhibitory Autophosphorylation of CaMKII Controls PSD Association, Plasticity, and Learning
Elgersma, Y., Fedorov, N. B., Ikonen, S., Choi, E. S., Elgersma, M., Carvalho, O. M., Giese, K. P., & Silva, A. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)01007-3 · Cited by 290
Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease
McNeill, T. H., Brown, S. A., Rafols, J. A., & Shoulson, I. (1988) · Brain Research · doi:10.1016/0006-8993(88)90124-2 · Cited by 246 · cited 2×
“For example, enduring changes in MSN dendrites have been reported in Parkinson’s disease (McNeill et al., 1988; Ingham et al., 1998; Arbuthnott et al., 2000; Meshul et al., 2000; Zaja-Milatovic et al., 2005) and in a rat model of parkinsonism induced by 6-hydroxydopamine (6-OHDA)”
Background
Cited by
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
Brigman, J. L., Wright, T., Talani, G., Prasad-Mulcare, S., Jinde, S., Seabold, G. K., Mathur, P., Davis, M. I., Bock, R., Gustin, R. M., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0640-10.2010 · Cited by 339
Self-citationAge-related changes in glutathione and glutathione-related enzymes in rat brain
Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 277
Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome
Mulherkar, S. A., & Jana, N. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.002 · Cited by 71
Mohanan, A. G., Gunasekaran, S., Jacob, R. S., & Omkumar, R. V. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.855752 · Cited by 55
Metadata
- Authors
- Brown, A. M., Deutch, A. Y., & Colbran, R. J.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 22
- Issue
- 1
- Pages
- 247-256
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2115110011
- Cited by
- 93
- References
- 13
- FWCI
- 3.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. https://app.cochat.ai/papers/10.1111/j.1460-9568.2005.04190.x
- The paper
- Brown, A. M., Deutch, A. Y., & Colbran, R. J. (2005). Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2005.04190.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.